La vendita allo scoperto per BioNexus Gene Lab dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di BioNexus Gene Lab. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

BioNexus Gene Lab (NASDAQ:BGLC) Azioni, Report sulle vendite allo scoperto

BioNexus Gene Lab

BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.

BioNexus Gene Lab Corp

U.S. stocks could open on a tentative note on Tuesday after the <a href="https://www.benzinga.com/news/earnings/24/11/41696201/market-volatility-soars-ahead-of-elections-tech-earnings-mixed-strikes-and-hurricanes-knock-employm">averages registered a mixed October</a>. Futures of all three major indices were slightly up on Tuesday, pointing to a cautious sentiment on Wall Street.
While the S&amp;P 500 and Dow Jones snapped their six-week winning streak, the Nasdaq Composite chalked its seventh straight week of gains to round off a volatile October.
America goes to polls on Tuesday to elect its 47th president, and data so far suggests that it will be a neck-to-neck race between Democratic candidate&nbsp;Kamala Harris&nbsp;and Republican nominee&nbsp;Donald Trump.
Another factor playing on investors' minds will be the Federal Open Market Committee's (FOMC) rate decision – the prevailing sentiment is that the Fed will deliver a 25-basis point cut.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Performance (+/-)</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>0.27%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.16%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>0.12%</td>
</tr>
<tr>
<td>R2K</td>
<td>0.05%</td>
</tr>
</tbody>
</table>
</figure>
In premarket trading on Tuesday,&nbsp;the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) rose 0.16% to $570.71 and the&nbsp;Invesco QQQ ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) edged up by 0.25% to $487.24, according to&nbsp;<a href="https://benzinga.grsm.io/lxquj26b2sag" target="_blank" rel="noreferrer noopener">Benzinga Pro data</a>.
Cues From Last Session:
The Dow Jones tumbled over 250 points on Monday, closing the day down by 0.61%. The other two averages also declined amid declining investor sentiment and rising fear in the market.
Oil prices continued to rebound after tanking the week before, amid delays in production output increase by the Organization of the Petroleum Exporting Countries, or OPEC.
Treasury yields continued to rise, signaling concerns that regardless of who wins the elections, the next administration might struggle with fiscal discipline. This sentiment was further exacerbated by the International Monetary Fund's warnings on the long-term trajectory <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41495286/deficit-strain-in-washington-will-get-worse-imf-warns-national-debt-projections-rev" target="_blank" rel="noreferrer noopener">of the U.S. national debt</a>.
On the economic data front, U.S. factory orders declined by 0.5% from the previous month to $584.2 billion in September compared to a revised 0.8% fall in August.
Most sectors on the S&amp;P 500 closed on a negative note, with utilities, communication services, and financials stocks recording the biggest losses on Monday.
However, energy and real estate stocks bucked the overall market trend, closing the session higher.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>-0.33%</td>
<td>18,179.98</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.28%</td>
<td>5,712.62</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.61%</td>
<td>41,794.60</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>0.40%</td>
<td>2,219.03</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
Ryan Detrick, chief market strategist at Carson Group, underscored that stocks perform well on election day, which could assuage investor concerns amid rising volatility.
"What really stands out is how well stocks have done after the 10 most recent elections. Higher a year later 9 times and up 15.2% on avg (median of 17.2%)," he said.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Here&#39;s how stocks have done after the past 24 elections. What really stands out is how well stocks have done after the 10 most recent elections. Higher a year later 9 times and up 15.2% on avg (median of 17.2%). <a href="https://t.co/ztim9o3RxP">pic.twitter.com/ztim9o3RxP</a>
&mdash; Ryan Detrick, CMT (@RyanDetrick) <a href="https://twitter.com/RyanDetrick/status/1853476226741989530?ref_src=twsrc%5Etfw">November 4, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Echoing Detrick's sentiment, WisdomTree and Wharton School economist&nbsp;Jeremy Siegel said the equity bull run could continue.
"In the near term, stock markets seem poised for further gains, bolstered by resilient earnings and steady economic fundamentals, while bond markets will likely grapple with higher yields and volatility ahead," he said.
"The bull market in stocks looks set to continue, while bonds face a rougher road."
See Also: <a href="https://www.benzinga.com/money/how-to-trade-futures">How To Trade Futures</a>
Upcoming Economic Data
Tuesday's economic calendar is fairly light.
<ul>
<li>On Tuesday, U.S. trade deficit data will be released at 8:30 a.m. ET.</li>
<li>ISM services data will be released at 10 a.m. ET.</li>
<li>API weekly crude oil stock data will be released at 4:30 p.m. ET.</li>
</ul>
Stocks In Focus:
<ul>
<li>Trump Media &amp; Technology Group Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>) shares soared 5.6% on election eve.</li>
<li>Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) shares surged 13% in premarket trading after the company delivered strong performance and raised guidance.</li>
<li>Boeing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) shares rose nearly 2% after striking machinists ratified a new deal late Monday, ending a seven-week-long strike.</li>
<li>NXP Semiconductors NV (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPI#NASDAQ">NXPI</a>) stock fell over 5% after the company's soft guidance, despite beating expectations in the September quarter.</li>
<li>Investors are awaiting earnings results from Archer-Daniels-Midland Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADM#NYSE">ADM</a>), Yum! Brands, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUM#NYSE">YUM</a>) and Cummins Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMI#NYSE">CMI</a>) today.</li>
</ul>
Commodities, Bonds And Global Equity Markets:
Crude oil futures surged in the early New York session, rising by 0.4% after OPEC announced a delay in increasing production.
The 10-year Treasury note yield surged to 4.311%.
Major Asian markets ended in the green on Tuesday, and European stocks showed strength as well in early trading.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/11/41736062/boeing-workers-end-seven-week-strike-by-accepting-new-contract-with-major-pay-increases">Boeing Workers End Seven-Week Strike By Accepting New Contract With Major Pay Increases</a></li>
</ul>
Photo courtesy: Wikimedia

Earnings

Equities

News

Futures

Economics

Federal Reserve

Pre-Market Outlook

Markets

Movers

Trading Ideas

NXPI

PLTR

US Stocks Set For Cautious Start As Investors Brace For Volatility On Election Day: Expert Points To 'Pretty Well Overall' Historical Performance

WIIM

WYNN

Wynn Resorts shares are trading lower after the company reported worse-than-expected Q3 EPS and revenues.

AZPN

Emerson Proposes To Acquire Remaining Outstanding Shares Of AspenTech For $240 Per Share In Cash

Fiscal 2025 Guidance
Certain statements in this release, including without limitation, those in this section, are forward-looking statements. For additional information regarding the use and limitations of such statements, refer to "Cautionary Note Regarding Forward-Looking Statements" below.
Based on results for the first quarter of fiscal 2025 and its current outlook for the remainder of the fiscal year, the company is reaffirming the following:
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">Guidance Metric</td>
<td colspan="1" rowspan="1">Fiscal 2025 Guidance Range [1] [2] (as of November 5, 2024)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Segment Net Revenue:</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Supply Chain Services</td>
<td colspan="1" rowspan="1">$560 million to $610 million</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Performance Services Excluding Contigo Health</td>
<td colspan="1" rowspan="1">$370 million to $410 million</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Total Net Revenue Excluding Contigo Health</td>
<td colspan="1" rowspan="1">$930 million to $1.02 billion</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted EBITDA</td>
<td colspan="1" rowspan="1">$235 million to $255 million</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted EPS</td>
<td colspan="1" rowspan="1">$1.16 to $1.28</td>
</tr>
<tr>
<td colspan="2" rowspan="1">
Fiscal 2025 guidance is based on the realization of the following key assumptions:
<ul>
<li>Net administrative fees revenue of $495 million to $525 million, which includes $60 million to $75 million in revenue related to non-healthcare member purchasing</li>
<li>Supply Chain Services segment software licenses, other services and support revenue of $65 million to $85 million</li>
<li>Capital expenditures of $90 million to $100 million</li>
<li>Effective income tax rate in the range of 25% to 27%</li>
<li>Cash income tax rate of less than 5%</li>
<li>Free cash flow of 45% to 55% of adjusted EBITDA</li>
</ul>
</td>
</tr>
</tbody>
</table>
</figure>

Guidance

PINC

Premier Expects FY25 Net Revenue Of $930M-$1.02B Vs $977.19M Est, Adj EPS Of $1.16-$1.28 Vs $1.21 Est

Emerson Commences Review Of Strategic Options For Safety & Productivity Segment

JMP Securities analyst Jordan Bender upgrades Century Casinos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTY#NASDAQ">CNTY</a>) from Market Perform to Market Outperform and announces $5 price target.

Upgrades

Price Target

Analyst Ratings

CNTY

JMP Securities Upgrades Century Casinos to Market Outperform, Announces $5 Price Target

Sophia Genetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOPH#NASDAQ">SOPH</a>) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.22) by 27.27 percent. This is a 33.33 percent decrease over losses of $(0.21) per share from the same period last year. The company reported quarterly sales of $15.853 million which beat the analyst consensus estimate of $15.850 million by 0.02 percent. This is a 2.76 percent decrease over sales of $16.303 million the same period last year.

Earnings Beats

Earnings Misses

SOPH

Sophia Genetics Q3 2024 GAAP EPS $(0.28) Misses $(0.22) Estimate, Sales $15.853M Beat $15.850M Estimate

Celanese shares are trading lower after the company reported worse-than-expected Q3 financial results and announced it intends to temporarily reduce its quarterly dividend.

Truist Securities analyst Jamie Cook downgrades Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) from Buy to Hold and lowers the price target from $46 to $43.

Downgrades

CGNX

Truist Securities Downgrades Cognex to Hold, Lowers Price Target to $43

Buybacks

Emerson Reveals Increased Return of Capital To Shareholders With Plans To Repurchase Approximately $2B Of Shares In FY25; Expecting $1B In Fiscal Q1

Boyd Gaming (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BYD#NYSE">BYD</a>) released its Q3 earnings on Thursday, October 24, 2024 at 04:05 PM.
Here's what's important from the earnings announcement.
<h3>Earnings</h3>
Boyd Gaming beat estimated earnings by 10.0%, reporting an EPS of $1.52 versus an estimate of $1.38.
Revenue was up $58.08 million from the same period last year.
<h3>Analysis of Past Earnings</h3>
The company beat on EPS by $0.09 in the last quarter, resulting in a 4.0% increase share price change the following day.
Here's a look at Boyd Gaming's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.38</td>
<td>1.49</td>
<td>1.57</td>
<td>1.47</td>
<td>1.47</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.52</td>
<td>1.58</td>
<td>1.51</td>
<td>1.66</td>
<td>1.36</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>912.95M</td>
<td>909.06M</td>
<td>958.74M</td>
<td>930.47M</td>
<td>879.82M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>961.25M</td>
<td>967.51M</td>
<td>960.52M</td>
<td>954.41M</td>
<td>903.16M</td>
</tr>
</tbody>
</table>

<h3>Competitors' Recent Earnings Updates</h3>
It's important to consider Boyd Gaming's numbers in relation to how its competitors, like PENN Entertainment, Golden Entertainment, and Inspired Entertainment, have been performing.
<ul>
<li>PENN Entertainment announced strong earnings on August 08, 2024, surpassing market expectations. Despite an estimated EPS of $-0.26, PENN Entertainment's actual EPS was $-0.18, reflecting a 30.77% increase.</li>
<li>Despite market projections of an EPS of $0.21, Golden Entertainment's earnings on August 08, 2024 fell short with an actual EPS of $0.02, representing a -90.48% decrease from expectations.</li>
<li>The latest earnings announcement from Inspired Entertainment on August 08, 2024 exceeded expectations, with an actual EPS of $0.2 compared to the market's estimate of $0.1, resulting in a 100.0% increase.</li>
</ul>
<h3>Insights into Competitors' Quarterly Earnings and Stock Performance</h3>
The analysis presented here offers insights into the market's response to the latest earnings releases of key competitors. It highlights the expected and announced earnings per share (EPS) for each company, along with their corresponding stock prices at the close of the announcement day and the open of the following trading day.

<table>
<thead>
<tr>
<th>Company Name</th>
<th>Date</th>
<th style="text-align: right;">EPS Expected</th>
<th style="text-align: right;">EPS Announced</th>
<th>EPS Change Percent</th>
<th>Stock Price At Close</th>
<th>Stock Price at Next Day Open</th>
<th>Price Change Percent</th>
</tr>
</thead>
<tbody>
<tr>
<td>Boyd Gaming</td>
<td>October 24, 2024</td>
<td style="text-align: right;">1.38</td>
<td style="text-align: right;">1.52</td>
<td>10.14%</td>
<td>$64.31</td>
<td>$69.96</td>
<td>8.79%</td>
</tr>
<tr>
<td>PENN Entertainment</td>
<td>August 08, 2024</td>
<td style="text-align: right;">-0.26</td>
<td style="text-align: right;">-0.18</td>
<td>30.77%</td>
<td>$18.72</td>
<td>$18.83</td>
<td>0.59%</td>
</tr>
<tr>
<td>Golden Entertainment</td>
<td>August 08, 2024</td>
<td style="text-align: right;">0.21</td>
<td style="text-align: right;">0.02</td>
<td>-90.48%</td>
<td>$28.12</td>
<td>$27.42</td>
<td>-2.49%</td>
</tr>
<tr>
<td>Inspired Entertainment</td>
<td>August 08, 2024</td>
<td style="text-align: right;">0.10</td>
<td style="text-align: right;">0.20</td>
<td>100.0%</td>
<td>$8.48</td>
<td>$8.39</td>
<td>-1.06%</td>
</tr>
</tbody>
</table>

<h3>Analyzing Peer Revenue Discrepancy: Estimated vs. Announced</h3>
Here's a comparison table presenting estimated and announced revenue figures for Boyd Gaming's peers. This comparison offers insights into the revenue performance of these companies, providing valuable context for understanding their financial standing within the industry.

<table>
<thead>
<tr>
<th>Company Name</th>
<th>Estimated Revenue</th>
<th>Announced Revenue</th>
<th>Revenue Surprise Percentage</th>
</tr>
</thead>
<tbody>
<tr>
<td>Boyd Gaming</td>
<td>912.95M</td>
<td>961.25M</td>
<td>5.29%</td>
</tr>
<tr>
<td>PENN Entertainment</td>
<td>1.66B</td>
<td>1.66B</td>
<td>0.18%</td>
</tr>
<tr>
<td>Golden Entertainment</td>
<td>174.60M</td>
<td>167.33M</td>
<td>-4.16%</td>
</tr>
<tr>
<td>Inspired Entertainment</td>
<td>74.41M</td>
<td>75.60M</td>
<td>1.6%</td>
</tr>
</tbody>
</table>

To track all earnings releases for Boyd Gaming <a href="https://www.benzinga.com/quote/BYD/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Boyd Gaming Earnings Review: Q3 Summary

AG Mortgage Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MITT#NYSE">MITT</a>) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $0.16 by 6.25 percent.

MITT

AG Mortgage Investment Q3 2024 Adj EPS $0.17 Beats $0.16 Estimate

NXP Semiconductors shares are trading lower after the company issued soft guidance.

2024 Outlook
The company raised its 2024 outlook for organic revenue growth to reflect strong year-to-date performance. All other measures in the outlook were maintained.
The company's outlook for 2024 in the table below assumes constant currency rates and excludes the impact of any future acquisitions or dispositions that may occur during the remainder of the year. Thomson Reuters believes that this type of guidance provides useful insight into the anticipated performance of its businesses.
The company expects its fourth-quarter 2024 organic revenue growth to be approximately 5% and its adjusted EBITDA margin to be approximately 37%.
The company continues to operate in an uncertain macroeconomic environment, reflecting ongoing geopolitical risk, uneven economic growth and an evolving interest rate and inflationary backdrop. Any worsening of the global economic or business environment, among other factors, could impact the company's ability to achieve its outlook.
Reported Full-Year 2023 Results and Full-Year 2024 Outlook
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">Total Thomson Reuters</td>
<td colspan="1" rowspan="1">
FY 2023
Reported
</td>
<td colspan="1" rowspan="1">
FY 2024
Outlook
2/8/2024
</td>
<td colspan="1" rowspan="1">
FY 2024
Outlook
5/2/2024
</td>
<td colspan="1" rowspan="1">
FY 2024
Outlook
8/1/2024
</td>
<td colspan="1" rowspan="1">
FY 2024
Outlook
11/5/2024
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Total Revenue Growth</td>
<td colspan="1" rowspan="1">3&nbsp;%</td>
<td colspan="1" rowspan="1">~ 6.5%</td>
<td colspan="1" rowspan="1">6.5% - 7.0%</td>
<td colspan="1" rowspan="1">~ 7.0%</td>
<td colspan="1" rowspan="1">Unchanged</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Organic Revenue Growth(1)</td>
<td colspan="1" rowspan="1">6&nbsp;%</td>
<td colspan="1" rowspan="1">~ 6%</td>
<td colspan="1" rowspan="1">6.0% - 6.5%</td>
<td colspan="1" rowspan="1">~ 6.5%</td>
<td colspan="1" rowspan="1">~7.0%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted EBITDA Margin(1)</td>
<td colspan="1" rowspan="1">39.3&nbsp;%</td>
<td colspan="1" rowspan="1">~ 38%</td>
<td colspan="1" rowspan="1">Unchanged</td>
<td colspan="1" rowspan="1">Unchanged</td>
<td colspan="1" rowspan="1">Unchanged</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Corporate Costs</td>
<td colspan="1" rowspan="1">$115 million</td>
<td colspan="1" rowspan="1">$120 - $130 million</td>
<td colspan="1" rowspan="1">Unchanged</td>
<td colspan="1" rowspan="1">Unchanged</td>
<td colspan="1" rowspan="1">Unchanged</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Free Cash Flow(1)</td>
<td colspan="1" rowspan="1">$1.9 billion</td>
<td colspan="1" rowspan="1">~ $1.8 billion</td>
<td colspan="1" rowspan="1">Unchanged</td>
<td colspan="1" rowspan="1">Unchanged</td>
<td colspan="1" rowspan="1">Unchanged</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Accrued Capex as % of Revenues(1)</td>
<td colspan="1" rowspan="1">7.8&nbsp;%</td>
<td colspan="1" rowspan="1">~ 8.5%</td>
<td colspan="1" rowspan="1">Unchanged</td>
<td colspan="1" rowspan="1">Unchanged</td>
<td colspan="1" rowspan="1">Unchanged</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Depreciation &amp; Amortization of Computer Software
&nbsp;&nbsp;&nbsp; Depreciation &amp; Amortization of Internally
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Developed Software
&nbsp;&nbsp;&nbsp; Amortization of Acquired Software
</td>
<td colspan="1" rowspan="1">
$628 million
 $556 million
$72 million
</td>
<td colspan="1" rowspan="1">
$730 - $750 million
 $595 - $615 million
~ $135 million
</td>
<td colspan="1" rowspan="1">
Unchanged
 Unchanged
Unchanged
</td>
<td colspan="1" rowspan="1">
Unchanged
 $580 - $600 million
~ $150 million
</td>
<td colspan="1" rowspan="1">
Unchanged
 Unchanged
Unchanged
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Interest Expense (P&amp;L)(2)</td>
<td colspan="1" rowspan="1">$164 million(2)</td>
<td colspan="1" rowspan="1">$150 - $170 million</td>
<td colspan="1" rowspan="1">Unchanged</td>
<td colspan="1" rowspan="1">$125 - $145&nbsp; million</td>
<td colspan="1" rowspan="1">Unchanged</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Effective Tax Rate on Adjusted Earnings(1)</td>
<td colspan="1" rowspan="1">16.5&nbsp;%</td>
<td colspan="1" rowspan="1">~ 18%</td>
<td colspan="1" rowspan="1">Unchanged</td>
<td colspan="1" rowspan="1">Unchanged</td>
<td colspan="1" rowspan="1">Unchanged</td>
</tr>
</tbody>
</table>
</figure>

Thomson Reuters Affirms FY24 Sales Guidance Of $7.27B Vs. $7.28B Estimate

Enpro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NPO#NYSE">NPO</a>) reported quarterly earnings of $1.74 per share which missed the analyst consensus estimate of $1.87 by 6.95 percent. The company reported quarterly sales of $260.900 million which missed the analyst consensus estimate of $264.467 million by 1.35 percent. This is a 4.07 percent increase over sales of $250.700 million the same period last year.

Enpro Q3 2024 Adj. EPS $1.74 Misses $1.87 Estimate, Sales $260.900M Miss $264.467M Estimate

Palantir shares are trading higher after the company reported better-than-expected Q3 financial results and issued guidance above consensus estimates.

MNDO

MIND C.T.I. Q3 EPS $0.04 Down From $0.06 YoY, Sales $5.21M Down From $5.26M YoY

Truist Securities analyst Jamie Cook upgrades MasTec (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTZ#NYSE">MTZ</a>) from Hold to Buy and raises the price target from $133 to $173.

Truist Securities Upgrades MasTec to Buy, Raises Price Target to $173

Enpro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NPO#NYSE">NPO</a>) lowers FY2024 Adj EPS guidance from $7.00-7.60 to $6.75-7.00 vs $7.27 analyst estimate..

Enpro Lowers FY2024 Adj EPS Guidance from $7.00-7.60 to $6.75-7.00 vs $7.27 Est

Westlake Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>) reported quarterly earnings of $0.51 per share which beat the analyst consensus estimate of $0.36 by 41.67 percent. The company reported quarterly sales of $276.995 million which beat the analyst consensus estimate of $244.000 million by 13.52 percent. This is a 13.89 percent decrease over sales of $321.664 million the same period last year.

WLKP

Westlake Chemical Q3 2024 GAAP EPS $0.51 Beats $0.36 Estimate, Sales $276.995M Beat $244.000M Estimate

The latest update is out from BioNexus Gene Lab Corp (BGLC). The Company recently announced a strategic investment in Ascension Innovation Sdn Bhd,...

BioNexus Gene Lab Expands Reach with Strategic Investment

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Friday is here and we&rsquo;re breaking down the biggest pre-market stock movers that traders need to know about this morning!



Moving stocks this morning are shareholder meetings, earnings reports, a dividend and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Redwoods Acquisition (NASDAQ:<a href="https://investorplace.com/stock-quotes/rwodu-stock-quote/">RWODU</a>) stock is rocketing more than 84% on <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318243471&amp;type=PDF&amp;symbol=RWOD&amp;cdn=b571d8a48f5cf4a43db1e1aee09248ab&amp;companyName=Redwoods+Acquisition+Corp.&amp;formType=425&amp;formDescription=Prospectuses+and+communications%2C+business+combinations&amp;dateFiled=2024-04-18">details of a shareholder meeting</a>.</li>



<li>Zhongchao (NASDAQ:<a href="https://investorplace.com/stock-quotes/zcmd-stock-quote/">ZCMD</a>) shares are soaring over 83% with heavy pre-market trading.</li>



<li>Redwoods Acquisition (NASDAQ:<a href="https://investorplace.com/stock-quotes/rwod-stock-quote/">RWOD</a>) stock is also surging more than 69% on that shareholder meeting.</li>



<li>Wang &amp; Lee (NASDAQ:<a href="https://investorplace.com/stock-quotes/wlgs-stock-quote/">WLGS</a>) shares are gaining over 33% with its <a href="https://www.nasdaq.com/press-release/wang-lee-group-inc.-announces-fiscal-year-2023-financial-results-2024-04-18">2023 earnings report</a>.</li>



<li>Next e GO (NASDAQ:<a href="https://investorplace.com/stock-quotes/egox-stock-quote/">EGOX</a>) stock is increasing more than 23% on strong early morning trading.</li>



<li>Ault Alliance (NYSEMKT:<a href="https://investorplace.com/stock-quotes/ault-stock-quote/">AULT</a>) shares are rising over 23% after <a href="https://finance.yahoo.com/news/ault-alliance-declares-monthly-cash-103000927.html">announcing a cash dividend</a>.</li>



<li>Hub Cyber Security (NASDAQ:<a href="https://investorplace.com/stock-quotes/hubc-stock-quote/">HUBC</a>) stock is climbing more than 23% with heavy trading this morning.</li>



<li>Trio Petroleum (NYSEMKT:<a href="https://investorplace.com/stock-quotes/tpet-stock-quote/">TPET</a>) shares are jumping close to 22% as it <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318243734&amp;type=PDF&amp;symbol=TPET&amp;cdn=802b738c707aac03352a0b144f6bbbb7&amp;companyName=Trio+Petroleum+Corp.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-04-19">plans for an annual shareholder meeting</a>.</li>



<li>Richtech Robotics (NASDAQ:<a href="https://investorplace.com/stock-quotes/rr-stock-quote/">RR</a>) stock is getting an over 20% boost despite a lack of news this morning.</li>



<li>Centogene (NASDAQ:<a href="https://investorplace.com/stock-quotes/cntg-stock-quote/">CNTG</a>) shares are up more than 19% without any apparent news today.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Tritium DCFC (NASDAQ:<a href="https://investorplace.com/stock-quotes/dcfc-stock-quote/">DCFC</a>) stock is crashing over 61% after <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318241881&amp;type=PDF&amp;symbol=DCFC&amp;cdn=21bc4c0fb2af1dc1e7b76f221263a80e&amp;companyName=Tritium+DCFC+Limited&amp;formType=6-K&amp;formDescription=Report+of+foreign+private+issuer+pursuant+to+Rule+13a-16+or+15d-16+under+the+Securities+Exchange+Act+of+1934&amp;dateFiled=2024-04-18">warning of insolvency</a>.</li>



<li>BioNexus Gene Lab (NASDAQ:<a href="https://investorplace.com/stock-quotes/bglc-stock-quote/">BGLC</a>) shares are plummeting more than 23% following a <a href="https://www.nasdaq.com/press-release/bionexus-gene-lab-corp.-agrees-to-invest-rm-1.2-million-in-ascension-innovation-aisb">rally late yesterday</a>.</li>



<li>Tian Ruixiang (NASDAQ:<a href="https://investorplace.com/stock-quotes/tirx-stock-quote/">TIRX</a>) stock is diving over 18% after a <a href="https://investorplace.com/2024/04/why-is-tian-ruixiang-tirx-stock-up-209-today/">massive rally yesterday</a>.</li>



<li>iSpecimen (NASDAQ:<a href="https://investorplace.com/stock-quotes/ispc-stock-quote/">ISPC</a>) shares are tumbling more than 17% after a major rally on Thursday.</li>



<li>Spectaire (NASDAQ:<a href="https://investorplace.com/stock-quotes/spec-stock-quote/">SPEC</a>) stock is taking an over 17% beating on Friday morning.</li>



<li>Sunshine Biopharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/sbfm-stock-quote/">SBFM</a>) shares are falling more than 16% this morning.</li>



<li>Moolec Science (NASDAQ:<a href="https://investorplace.com/stock-quotes/mlec-stock-quote/">MLEC</a>) stock is dropping nearly 16% with its <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318243156&amp;type=PDF&amp;symbol=MLEC&amp;cdn=8dae77192b72d42d8942b9dec934f931&amp;companyName=Moolec+Science+SA&amp;formType=6-K&amp;formDescription=Report+of+foreign+private+issuer+pursuant+to+Rule+13a-16+or+15d-16+under+the+Securities+Exchange+Act+of+1934&amp;dateFiled=2024-04-18">latest earnings release</a>.</li>



<li>AGBA Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/agba-stock-quote/">AGBA</a>) shares are retreating over 15% after <a href="https://investorplace.com/2024/04/why-is-agba-group-agba-stock-up-149-today/">soaring yesterday on merger plans</a>.</li>



<li>MariaDB (NYSE:<a href="https://investorplace.com/stock-quotes/mrdb-stock-quote/">MRDB</a>) stock is decreasing more than 13% this morning.</li>



<li>Invo Bioscience (NASDAQ:<a href="https://investorplace.com/stock-quotes/invo-stock-quote/">INVO</a>) shares close out our pre-market stock movers down over 13% after <a href="https://investorplace.com/2024/04/why-is-invo-bioscience-invo-stock-up-85-today/">a recent rally</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-april-19th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
BioNexus Gene Lab&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/bglc-stock-quote/">BGLC</a>) stock is falling on Friday but investors will note that this comes after its shares underwent a rally late on Thursday.



BioNexus Gene Lab shares closed out Thursday up 28.8% with about 3.1 million units traded. That was more than its daily average trading volume of about 1.6 million shares.



The catalyst for this rally was BioNexus Gene Lab announcing its agreement to <a href="https://www.nasdaq.com/press-release/bionexus-gene-lab-corp.-agrees-to-invest-rm-1.2-million-in-ascension-innovation-aisb">invest $250,000 in Ascension Innovation</a>. This is a privately held Malaysian company focused on advancing digital health information with artificial intelligence (<a href="https://investorplace.com/stock-quotes/ai-stock-quote/">AI</a>).



Sam Tan, CEO, BioNexus Gene Lab, said this about the news.




&ldquo;Our investment in AISB reflects our belief in their transformative healthcare solutions. Together, we aim to revolutionize patient care through predictive and generative AI.&rdquo;




AI has been a hot topic lately with news of it often raising a company&rsquo;s shares. Yesterday&rsquo;s gains were likely the result of traders flocking to BGLC stock due to the AI connection with this investment.



<h2>BGLC Stock Movement on Friday</h2>



Unfortunately, it doesn&rsquo;t look like BGLC is able to maintain the positive movement it saw yesterday. This has the stock down 26.8% during pre-market hours on Friday. However, this doesn&rsquo;t come with heavy trading as only around 66,000 units have changed hands this morning.



Investors will see even more of the latest stock market stories below!



We have all of the hottest market news traders need to know about on Friday! That includes everything happening with shares of Tritium DCFC&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/dcfc-stock-quote/">DCFC</a>) stock, Zhongchao&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/zcmd-stock-quote/">ZCMD</a>) stock and Redwoods Acquisition&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/rwod-stock-quote/">RWOD</a>) stock today. You can catch up on all of these matters at the following links!



<h2>More Stock Market News for Friday</h2>



<ul><li><a href="https://investorplace.com/2024/04/why-is-tritium-dcfc-dcfc-stock-down-63-today/">Why Is Tritium DCFC (DCFC) Stock Down 63% Today?</a></li>



<li><a href="https://investorplace.com/2024/04/why-is-zhongchao-zcmd-stock-up-103-today/">Why Is Zhongchao (ZCMD) Stock Up 103% Today?</a></li>



<li><a href="https://investorplace.com/2024/04/why-is-redwoods-acquisition-rwod-stock-up-72-today/">Why Is Redwoods Acquisition (RWOD) Stock Up 72% Today?</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/why-is-bionexus-gene-lab-bglc-stock-down-27-today/">Why Is BioNexus Gene Lab (BGLC) Stock Down 27% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is BioNexus Gene Lab (BGLC) Stock Down 27% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Redwoods Acquisition (NASDAQ:<a href="https://investorplace.com/stock-quotes/rwod-stock-quote/">RWOD</a>) stock is in the news Friday as after the special purpose acquisition company (SPAC) got <a href="https://investorplace.com/2024/04/why-is-redwoods-acquisition-rwod-stock-up-72-today/">approval from shareholders</a> for its merger with Anew Medical.



Let&rsquo;s get into everything traders need to know about the SPAC merger between Redwoods Acquisition and Anew Medical below!



<h2>RWOD Stock SPAC Merger Details</h2>



<ul><li>Redwoods Acquisition and Anew Medical first <a href="https://www.biospace.com/article/releases/anew-medical-announces-key-patent-issued-in-china-to-protect-klotho-protein-and-gene-delivery-systems/#:~:text=In%20May%202023%2C%20ANEW%20announced,to%20be%20listed%20on%20NASDAQ">entered into this merger agreement</a> in May 2023 with plans for ANEW stock to start trading in March 2024.</li>



<li>While there&rsquo;s been a slight delay to that this latest shareholder vote paves the way for Anew Medical to take over the combined company once the merger is complete.</li>



<li>When the two companies combine they will focus on Anew Medical&rsquo;s goals.</li>



<li>The <a href="https://www.anewmeds.com/">company is focused on the</a> &ldquo;development of disease-modifying therapies for age-related cognitive and neurodegenerative disorders and cancer.&rdquo;</li>



<li>This will have it further develop its &aacute;-Klotho gene therapy research programs.</li>



<li>Anew Medical also notes that it doesn&rsquo;t believe there&rsquo;s much competition in this space due to its strong intellectual property position.</li>



<li>Leading Anew Medical is Dr. Joseph Sinkule with 40 years of experience in the drug development, research and commercialization markets.</li>
</ul>RWOD stock is up 66.5% as of Friday morning with more than 4 million shares changing hands. That&rsquo;s well above its daily average trading volume of about 11,000 shares.



Investors will find more of the most recent stock market stories ready to go down below!



We have all of the hottest stock market news available on Friday! Among that is what has shares of Trump Media&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/djt-stock-quote/">DJT</a>), BioNexus Gene Lab&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/bglc-stock-quote/">BGLC</a>) and Tritium DCFC&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/dcfc-stock-quote/">DCFC</a>) stock moving today. All of that info is available below!



<h2>More Friday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/04/djt-stock-pops-as-trump-media-takes-on-short-sellers/">DJT Stock Pops as Trump Media Takes On Short Sellers</a></li>



<li><a href="https://investorplace.com/2024/04/why-is-bionexus-gene-lab-bglc-stock-down-27-today/">Why Is BioNexus Gene Lab (BGLC) Stock Down 27% Today?</a></li>



<li><a href="https://investorplace.com/2024/04/why-is-tritium-dcfc-dcfc-stock-down-63-today/">Why Is Tritium DCFC (DCFC) Stock Down 63% Today?</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/rwod-stock-7-things-to-know-about-the-anew-medical-merger/">RWOD Stock: 7 Things to Know About the Anew Medical Merger</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

RWOD Stock: 7 Things to Know About the Anew Medical Merger

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Marathon Digital (NASDAQ:<a href="https://investorplace.com/stock-quotes/mara-stock-quote/">MARA</a>) stock is on the rise Friday as the Bitcoin (<a href="https://investorplace.com/cryptocurrency/btc-usd/">BTC-USD</a>) mining company prepares for the token&rsquo;s halving event.



That Bitcoin halving is expected to take place <a href="https://www.cnbc.com/2024/04/18/jpmorgan-likes-these-mining-stocks-to-play-the-upcoming-bitcoin-halving.html">either today or sometime tomorrow</a>. When this happens, the reward for mining BTC will be reduced. That&rsquo;s a big deal for MARA stock and other Bitcoin mining shares.



The pressure of the upcoming Bitcoin halving has been weighing on mining stocks but that might not be a bad thing. While this has MARA stock down 32.4% year-to-date, this weakness could make for an attractive entry point.



It also bears mentioning that Marathon Digital and other Bitcoin mining companies are <a href="https://investorplace.com/2024/04/why-marathon-digital-stock-is-worth-buying-ahead-of-the-bitcoin-halving/">better prepared for the halving</a> this time around. That has them ordering new miners, increasing electricity flows and taking other actions to prepare for the event.



<h2>What The Bitcoin Halving Means for MARA Stock</h2>



One thing that traders in MARA will keep in mind is the effects of the Bitcoin halving. Experts are predicting that the event will send the token higher. That includes it surpassing its previous all-time high. This could be a major boon to BTC miners.



MARA stock is up 2.1% as of Friday morning with more than 12 million shares traded. That&rsquo;s still below its daily average trading volume of about 66 million shares.



Investors will find even more of the most recent stock market stories below!



We have all of the hottest stock market news investors need to know about on Friday! A few examples include what&rsquo;s happening with shares of Redwoods Acquisition&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/rwod-stock-quote/">RWOD</a>), Trump Media&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/djt-stock-quote/">DJT</a>) and BioNexus Gene Lab&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/bglc-stock-quote/">BGLC</a>) stock today. All of that news is available at the following links!



<h2>More Stock Market News for Friday</h2>



<ul><li><a href="https://investorplace.com/2024/04/rwod-stock-7-things-to-know-about-the-anew-medical-merger/">RWOD Stock: 7 Things to Know About the Anew Medical Merger</a></li>



<li><a href="https://investorplace.com/2024/04/djt-stock-pops-as-trump-media-takes-on-short-sellers/">DJT Stock Pops as Trump Media Takes On Short Sellers</a></li>



<li><a href="https://investorplace.com/2024/04/why-is-bionexus-gene-lab-bglc-stock-down-27-today/">Why Is BioNexus Gene Lab (BGLC) Stock Down 27% Today?</a></li>
</ul>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/mara-stock-alert-get-ready-for-the-bitcoin-halving/">MARA Stock Alert: Get Ready for the Bitcoin Halving</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

MARA Stock Alert: Get Ready for the Bitcoin Halving

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to start the trading week with a breakdown of the biggest pre-market stock movers worth reading about on Monday!



Moving stocks are the assassination attempt on former President Donald Trump, new agreements and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>DatChat (NASDAQ:<a href="https://investorplace.com/stock-quotes/dats-stock-quote/">DATS</a>) stock is rocketing more than 122% following <a href="https://www.cnn.com/politics/live-news/trump-rally-shooting-07-14-24/index.html">the assassination attempt</a> on former President Donald Trump.</li>



<li>Trump Media &amp; Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/djt-stock-quote/">DJT</a>) shares are soaring over 56% after the assassination attempt on the former President.</li>



<li>Phunware (NASDAQ:<a href="https://investorplace.com/stock-quotes/phun-stock-quote/">PHUN</a>) stock is surging more than 43% for those same reasons.</li>



<li>Pop Culture (NASDAQ:<a href="https://investorplace.com/stock-quotes/cpop-stock-quote/">CPOP</a>) shares are rising close to 38% alongside heavy pre-market trading.</li>



<li>Vince (NYSE:<a href="https://investorplace.com/stock-quotes/vnce-stock-quote/">VNCE</a>) stock is increasing over 23% without any news to report this morning.</li>



<li>Crown LNG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGBS#NASDAQ">CGBS</a>) shares are heading more than 18% higher with strong early morning trading today.</li>



<li>Valkyrie Bitcoin Futures Leveraged Strategy ETF (NASDAQ:<a href="https://investorplace.com/stock-quotes/btfx-stock-quote/">BTFX</a>) stock is climbing over 18% alongside a Bitcoin (<a href="https://investorplace.com/cryptocurrency/btc-usd/">BTC-USD</a>) rally</li>



<li>ProShares Trust ProShares Ultra Bitcoin ETF (NYSEARCA:<a href="https://investorplace.com/stock-quotes/bitu-stock-quote/">BITU</a>) shares are gaining more than 17% for the same reason.</li>



<li>Universe Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/upc-stock-quote/">UPC</a>) stock is jumping over 15% without any clear news this morning.</li>



<li>ProShares Trust ProShares Ultra Ether ETF (NYSEARCA:<a href="https://investorplace.com/stock-quotes/etht-stock-quote/">ETHT</a>) shares are up nearly 15% with a crypto rally.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Gamer Pakistan (NASDAQ:<a href="https://investorplace.com/stock-quotes/gpak-stock-quote/">GPAK</a>) stock is diving more than 25% without any clear news to report on Monday morning.</li>



<li>Qualigen Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/qlgn-stock-quote/">QLGN</a>) shares are tumbling over 23% <a href="https://investorplace.com/2024/07/why-is-qualigen-qlgn-stock-up-141-today/">after a recent rally</a>.</li>



<li>TDH (NASDAQ:<a href="https://investorplace.com/stock-quotes/petz-stock-quote/">PETZ</a>) stock is taking a more than 21% beating after a Friday rally.</li>



<li>Eastside Distilling (NASDAQ:<a href="https://investorplace.com/stock-quotes/east-stock-quote/">EAST</a>) shares are sliding over 21% despite a lack of news this morning.</li>



<li>Moolec Science (NASDAQ:<a href="https://investorplace.com/stock-quotes/mlec-stock-quote/">MLEC</a>) stock is dropping more than 18% <a href="https://www.stocktitan.net/news/MLEC/moolec-signs-an-offtake-agreement-with-major-global-cpg-company-to-sfqwiqzywbga.html">after signing an offtake agreement</a>.</li>



<li>Lottery.com (NASDAQ:<a href="https://investorplace.com/stock-quotes/ltry-stock-quote/">LTRY</a>) shares are decreasing over 17% on Monday morning.</li>



<li>ProShares Trust ProShares UltraShort Bitcoin ETF (NYSEARCA:<a href="https://investorplace.com/stock-quotes/sbit-stock-quote/">SBIT</a>) stock is falling more than 16% this morning.</li>



<li>Logistic Properties (NYSEMKT:<a href="https://investorplace.com/stock-quotes/lpa-stock-quote/">LPA</a>) shares are slipping over 15% after <a href="https://www.nasdaq.com/press-release/logistic-properties-americas-expands-board-appointments-two-independent-directors">adding two new directors</a>.</li>



<li>Locafy (NASDAQ:<a href="https://investorplace.com/stock-quotes/lcfy-stock-quote/">LCFY</a>) stock is dipping more than 15% today.</li>



<li>BioNexus Gene Lab (NASDAQ:<a href="https://investorplace.com/stock-quotes/bglc-stock-quote/">BGLC</a>) shares close out our pre-market stock movers down over 15% on Monday.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-july-15th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
BioNexus Gene Lab (NASDAQ:<a href="https://investorplace.com/stock-quotes/bglc-stock-quote/">BGLC</a>) just reported results for the second quarter of 2024.<ul><li>BioNexus Gene Lab reported earnings per share of 1.1 cents.</li><li>The company reported revenue of $1.98 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/bglc-stock-earnings-bionexus-gene-lab-for-q2-of-2024/">BGLC Stock Earnings: BioNexus Gene Lab Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

BGLC Stock Earnings: BioNexus Gene Lab Reported Results for Q2 2024

An announcement from BioNexus Gene Lab Corp (BGLC) is now available. BioNexus Gene Lab Corp. has strategically invested RM 1 million to acquire a s...

BioNexus Gene Lab's Strategic Investment in AI Healthcare

BioNexus Gene Lab Corp (BGLC) has shared an announcement. BioNexus Gene Lab Corp. announced a significant boost in confidence with a successful co-...

BioNexus Receives Government Backing for Healthcare Tech

BioNexus Gene Lab signs strategic partnership with Shenzhen Rongguang Group

AGBA

AULT

BGLC

BITU

BTFX

CGBS

CNTG

CPOP

DCFC

EAST

EGOX

ETHT

GPAK

HUBC

INVO

ISPC

LCFY

LTRY

MARA

MLEC

MRDB

PETZ

PHUN

QLGN

RWOD

RWODU

SBFM

SBIT

SPEC

TIRX

TPET

VNCE

ZCMD

Opinion

Press Releases

Thinking about buying stock in BioNexus Gene Lab, Gladstone Investment Corp, Canopy Growth Corp, Recursion Pharmaceuticals, or Monolithic Power Systems?

BioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in Healthcare

Financing

BioNexus Gene Lab Corp. Completes Strategic RM 1 Million Investment in Ascension Innovation Sdn Bhd

BioNexus Gene Lab Corp. Announces Successful Securities Commission of Malaysia (MyCIF) Co-Investment in Ascension Innovation Sdn Bhd

General

BioNexus Gene Lab Corp Announces New Business Developments for Subsidiary Chemrex with Investment in High-Quality Color Paste Production

BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and Preventative Healthcare Solutions

BioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement with VITARRAY Global Pte. Ltd.

BioNexus Gene Lab Corporation announces entry into Biogas Sector via Teaming Agreement with Protech Builders Sdn. Bhd.

Comments

BioNexus Gene Lab

Vendite allo scoperto

BioNexus Gene Lab (NASDAQ:BGLC) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO